CFTR and cystic fibrosis: The effect of estrogen on CFTR is supported by the abolition of the effect of E2 in decreasing ASL in non-CF cells after increasing the intracellular levels of cAMP using forskolin (an activator of the enzyme adenylyl cyclase).